Navigation Links
Chemical in Medical Technology

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

... Minn., July 7 /PRNewswire-USNewswire/ -- chemical dependency and recovery in patients and ... including potential tragedies, of prescription chemical addiction and abuse are being discussed, these ... Seattle , in "Anesthesiologists Recovering From chemical Dependency: Can They Safely Return to the ...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

... medical countermeasures against biological and chemical threats, today announced that it has submitted a ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ... and mortality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant ...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

... medical countermeasures against biological and chemical threats, today announced that the Company has ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ... and mortality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant ...

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

... medical countermeasures against biological and chemical threats, announced today that it will be hosting ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ... and mortality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant ...

Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology

... medical countermeasures against biological and chemical threats, announced today that new mechanism of ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ... and mortality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant ...

Nation's Laboratory Response Network Marks First Decade of Protecting Public Health

... diseases, toxic spills, natural disasters, chemical terrorism and other public health threats. ... across the network. In 2003, the LRN added a chemical component, the Laboratory Response Network for chemical Terrorism Preparedness, or LRN-C. Sixty-two ...

Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease

... Bakshi, Ph.D., is detailed in the American chemical Society's chemical Biology Journal , a leading online publisher of ... the Roskamp Institute and leads the Laboratory of chemical Biology and Drug Discovery in Neurology. Prior ...

PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)

... medical countermeasures against biological and chemical threats, today announced that dosing of ... models in preventing toxicity from exposure to chemical nerve agents. The randomized, ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ...

Technique for Rapidly Reprogramming Adult Cells Into Stem Cells Published in PLoS Biology

... mammalian embryos uses the combination of chemical inhibitors in SCS' Culticell iSTEM(TM) media ... inefficient, but now via the use of chemical inhibitors (of the enzymes MEK and GSK3) in ... from early stage embryos). The combination of chemical inhibitors used in this technique also forms the ...

Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels

... NEW YORK, Sept. 25 /PRNewswire/ -- Daiichi Fine chemical Co., Ltd. of Japan today announced that it has ... physicians in the area of study." Daiichi Fine chemical is a global leader in researching the use ... About Daiichi Fine Chemical Daiichi Fine chemical Co. Ltd., is the world's largest supplier of ...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... medical countermeasures against biological and chemical threats, announced today that the Company is ... medical countermeasures against biological and chemical weapons. PharmAthene's lead product development ... and mortality associated with exposure to chemical nerve agents -- RypVax(TM) -- a recombinant ...

Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network

... Center Network include: -- Burnham Center for chemical Genomics, Burnham Institute, La Jolla, Calif. ... Mass. -- Comprehensive Center for chemical Probe Discovery and Optimization at Scripps ... Johns Hopkins University, Baltimore, Md. -- NIH chemical Genomics Center, NIH/NHGRI, Rockville, Md. -- ...

Brain Stem Cells Can Be Awakened, Say Schepens Scientists

... part of the brain, but are mostly kept silent by chemical signals from support cells known as astrocytes. ... and turned into neurons. When they compared the chemical makeup of the areas known to generate new neurons ... to discover the exact nature of those different chemical signals. They learned that in the areas where ...

First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System

... in whom it has been possible to assess the chemical composition of coronary artery plaques and ... is the first device that can help assess the chemical make-up of coronary artery plaques and help ... contained in a plaque. The identification of the chemical composition of coronary plaques is expected to be ...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease

... of medical countermeasures against chemical and biological threats, announced today that ... (OP) nerve agent toxicity. About chemical Weapons Organophosphorous nerve agents, or ... discovery represents the beginning of modern chemical warfare. These agents cause toxicity by binding ...

ACC Concerned Over Reporting of Biomonitoring Results

... (CDC), "Just because people have an environmental chemical in their blood or urine does not mean that ... Biomonitoring data do not inform us about how the chemical was introduced, how long it has been there, or ... would occur at much, much lower doses. The chemical industry recognizes that environmental health ...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

... failure. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology ... may not be as expected, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of ...

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

... over standard anthracyclines and the rational design modifications to the chemical compound believed to be responsible for enhanced DNA damage and binding to ... as it is devoid of the putative cardiac toxicity generating chemical structure," said Barry W. Hancock, M.D., Professor of Medical Oncology, ...

Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat

... 2 /PRNewswire/ -- Dow AgroSciences, a wholly owned subsidiary of The Dow chemical Company (NYSE: DOW ), and World Wide Wheat (W3) LLC of Phoenix, Arizona, ... Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow chemical Company, are $4.5 billion. Learn more at www.dowagro.com . ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... -- For more than 10 years, Mark Wentland, professor of chemistry and chemical biology at Rensselaer Polytechnic Institute , led a Rensselaer team in ... and postdoctoral students in Rensselaer's Department of Chemistry and chemical Biology, along with Jean Bidlack, professor of pharmacology and physiology ...

Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis

... prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, ... diseases. About Merck Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.6 billion in 2008, a history that ...

SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

... sales of $624 million in 2008. SAFC is one of the world's top 10 fine chemical companies. For more information about SAFC, visit www.safcglobal.com . ... Sigma-Aldrich is a leading Life Science and High Technology company. Its chemical and biochemical products and kits are used in scientific research, ...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

... prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, ... diseases. About Merck Merck is a global pharmaceutical and chemical company with total revenues of euro 7.6 billion in 2008, a history that ...

Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures

... in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology ... may not be successful, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of ...

Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial

... prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, ... diseases. About Merck Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that ...

Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment

... substances into and out of the cell. Some are specialized for the flow of chemical ions such as sodium, potassium and calcium. The amount of ions of each ... the heart or blood vessels or rate of electrical firing or production of chemical messengers in nerve cells. Calcium antagonists block calcium channels. ...

Duska Therapeutics Completes Corporate Name Change to Cordex Pharma

... in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology ... may not be successful, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of ...

Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells

... (LAK) cells. AHCC also induces the production of cytokines that serve as chemical messengers between cells. AHCC has been the subject of over 80 research ... the formation of abnormal cells.* AHCC is manufactured by Amino Up chemical Company in Sapporo, Japan and is distributed in the United States by ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

... Jude scientists shows how microbes can block nitric oxide production - a chemical key to the immune system - and offers hints for fighting bacteria ... can block nitric oxide production in macrophages by breaking down the chemical arginine, which the macrophages need to make nitric oxide. "However, no ...

Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis

... prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, ... diseases. About Merck Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that ...

Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis

... prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, ... diseases. About Merck Merck is a global pharmaceutical and chemical company with total revenues of EUR 7.1 billion in 2007, a history that ...

First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting

... breakdown of acetylcholine, thereby increasing available levels of this chemical in the brain. There is an established association between the loss of acetylcholine, a brain chemical involved in memory and thinking, and AD. In a progressively degenerative ...

Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation

... platform, known as the Eligen(R) Technology, uses proprietary, synthetic chemical compounds, known as Emisphere delivery agents, sometimes called carriers. ... a target molecule (vitamin, therapeutic drug, etc.) without altering its chemical form or biological integrity. CONFERENCE CALL A teleconference to ...

Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD)

... uses a gentle, cold water and enzyme process avoiding heat, solvents, and chemical modifications that are utilized to process all other fish oils. This ... the use of extraction processes that use high temperatures, solvents and chemical modifications. Vectomega(R) is the only whole food omega 3 complex that is ...

BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University

... relevant to society's needs. About BASF BASF is the world's leading chemical company: The chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, ...

Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach

... of, a functional systemic RNAi delivery system that combines proprietary chemical modification and lipid technologies to achieve efficient intracellular ... independent publications by Judge(6) and Kim(2) also demonstrate that the chemical modification modality utilized in AtuRNAi obviates an immune response. ...

Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial

... drugs, known as the glycosaminoglycans. A variety of members of this chemical family have been shown to decrease pathological albumin excretion in diabetic nephropathy in humans. Some of the members of this chemical family include the following approved drugs: standard heparin, low ...

Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures

... pulsed light therapy -- Non-ablative laser therapy -- Ablative chemical peel -- Surgery -- Investigators gave ratings of "good" or ... pre and post-conditioning in combination with: -- Non-ablative chemical peel -- Microdermabrasion -- Ablative laser therapy -- ...

Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data

... drugs, known as the glycosaminoglycans. A variety of members of this chemical family have been shown to decrease pathological albumin excretion in diabetic nephropathy in humans. Some of the members of this chemical family include the following approved drugs: standard heparin, low ...

Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout

... The Company plans to have active development programs with four new chemical entities (NCEs) in the clinic for three distinct indications by the end of ... including its goal of having active development programs with four new chemical entities (NCEs) in the clinic for three distinct indications by the end of ...
Other Contents
(Date:11/5/2014)... the UTSA College of Sciences, is one of ... a two-year $300,00 National Science Foundation (NSF) Early ... supports President Obama,s BRAIN Initiative, a federal effort ... will demystify complex brain processes. , According ... into the interactions of multiple components, each working ...
(Date:11/4/2014)... Temple University School of Medicine announced today that ... initiative funded by the Bill & Melinda Gates ... Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair ... School of Medicine will pursue an innovative global ... Biomarkers to Assess Fetal Neurodevelopment.", Grand Challenges Explorations ...
(Date:11/4/2014)... Lithuania , Nov. 4, 2014   ... technologies, today announced that the latest version of ... in the Ongoing MINEX evaluation organized ... of fingerprint algorithms using the INCITS 378 fingerprint ... mandatory requirement in public tenders in ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3Temple University School of Medicine receives Grand Challenges Explorations grant 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3
(Date:11/27/2014)... Most babies and young children don,t need medicines if ... Administration says. Over-the-counter (OTC) cold and cough medicine ... because they could cause serious and potentially deadly side ... three colds a year, but children get them more ... to give them pain relievers, decongestants and other medicines, ...
(Date:11/27/2014)... York, NY (PRWEB) November 27, 2014 The ... to offering stylish, comfortable and high functioning compression socks, are ... The newly-released socks use an innovative Gradient Pressure (TM) knitting ... oxygenated blood. , VIM & VIGR’s commitment to adding flair ... of as just functional recently caught the eye of a ...
(Date:11/27/2014)... Two international trainers and lecturers on ... help one person with significant needs but limited means ... Dr. Mamaly Reshad of the Anacapa Dental Art Institute ... website devoted to helping dentist learn about using All-on-4™ ... be devoted to helping a patient who has damaged ...
(Date:11/27/2014)... 27, 2014 Developers and plugin specialist of ... entitled ProPip, taking FCPX to the next level. , “ProPip ... a few clicks of a mouse,” said Christina Austin, CEO ... our users will appreciate.” , With ProPip users can show ... possibilities truly endless. ProPip is great for commentaries, news casting, ...
(Date:11/27/2014)... 2014 Aria Health President and ... prepared and donated 200 Thanksgiving dinners on Friday, ... , a non-profit, community-based organization committed to serving ... The dinners were assembled in the dining hall ... distributed to vulnerable low income seniors in the ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2
Other TagsOther Tags